Cargando…
Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108069/ https://www.ncbi.nlm.nih.gov/pubmed/35598602 http://dx.doi.org/10.1016/j.ccell.2022.05.007 |
| _version_ | 1784708620848463872 |
|---|---|
| author | Stuver, Robert Shah, Gunjan L. Korde, Neha S. Roeker, Lindsey E. Mato, Anthony R. Batlevi, Connie L. Chung, David J. Doddi, Sital Falchi, Lorenzo Gyurkocza, Boglarka Hamilton, Audrey Lin, Ya-Hui Jakubowski, Ann A. Joffe, Erel Landau, Heather L. Lin, Richard J. Mailankody, Sham Palomba, M. Lia Park, Jae H. Perales, Miguel-Angel Ponce, Doris M. Ramanathan, Lakshmi V. Salles, Gilles A. Scordo, Michael Seo, Susan K. Shah, Urvi A. Stein, Eytan M. Straus, David Usmani, Saad Z. Young, James W. Zelenetz, Andrew D. Noy, Ariela Vardhana, Santosha A. |
| author_facet | Stuver, Robert Shah, Gunjan L. Korde, Neha S. Roeker, Lindsey E. Mato, Anthony R. Batlevi, Connie L. Chung, David J. Doddi, Sital Falchi, Lorenzo Gyurkocza, Boglarka Hamilton, Audrey Lin, Ya-Hui Jakubowski, Ann A. Joffe, Erel Landau, Heather L. Lin, Richard J. Mailankody, Sham Palomba, M. Lia Park, Jae H. Perales, Miguel-Angel Ponce, Doris M. Ramanathan, Lakshmi V. Salles, Gilles A. Scordo, Michael Seo, Susan K. Shah, Urvi A. Stein, Eytan M. Straus, David Usmani, Saad Z. Young, James W. Zelenetz, Andrew D. Noy, Ariela Vardhana, Santosha A. |
| author_sort | Stuver, Robert |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9108069 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91080692022-05-16 Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies Stuver, Robert Shah, Gunjan L. Korde, Neha S. Roeker, Lindsey E. Mato, Anthony R. Batlevi, Connie L. Chung, David J. Doddi, Sital Falchi, Lorenzo Gyurkocza, Boglarka Hamilton, Audrey Lin, Ya-Hui Jakubowski, Ann A. Joffe, Erel Landau, Heather L. Lin, Richard J. Mailankody, Sham Palomba, M. Lia Park, Jae H. Perales, Miguel-Angel Ponce, Doris M. Ramanathan, Lakshmi V. Salles, Gilles A. Scordo, Michael Seo, Susan K. Shah, Urvi A. Stein, Eytan M. Straus, David Usmani, Saad Z. Young, James W. Zelenetz, Andrew D. Noy, Ariela Vardhana, Santosha A. Cancer Cell Letter Elsevier Inc. 2022-06-13 2022-05-16 /pmc/articles/PMC9108069/ /pubmed/35598602 http://dx.doi.org/10.1016/j.ccell.2022.05.007 Text en © 2022 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter Stuver, Robert Shah, Gunjan L. Korde, Neha S. Roeker, Lindsey E. Mato, Anthony R. Batlevi, Connie L. Chung, David J. Doddi, Sital Falchi, Lorenzo Gyurkocza, Boglarka Hamilton, Audrey Lin, Ya-Hui Jakubowski, Ann A. Joffe, Erel Landau, Heather L. Lin, Richard J. Mailankody, Sham Palomba, M. Lia Park, Jae H. Perales, Miguel-Angel Ponce, Doris M. Ramanathan, Lakshmi V. Salles, Gilles A. Scordo, Michael Seo, Susan K. Shah, Urvi A. Stein, Eytan M. Straus, David Usmani, Saad Z. Young, James W. Zelenetz, Andrew D. Noy, Ariela Vardhana, Santosha A. Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies |
| title | Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies |
| title_full | Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies |
| title_fullStr | Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies |
| title_full_unstemmed | Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies |
| title_short | Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies |
| title_sort | activity of azd7442 (tixagevimab-cilgavimab) against omicron sars-cov-2 in patients with hematologic malignancies |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108069/ https://www.ncbi.nlm.nih.gov/pubmed/35598602 http://dx.doi.org/10.1016/j.ccell.2022.05.007 |
| work_keys_str_mv | AT stuverrobert activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT shahgunjanl activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT kordenehas activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT roekerlindseye activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT matoanthonyr activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT batleviconniel activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT chungdavidj activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT doddisital activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT falchilorenzo activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT gyurkoczaboglarka activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT hamiltonaudrey activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT linyahui activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT jakubowskianna activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT joffeerel activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT landauheatherl activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT linrichardj activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT mailankodysham activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT palombamlia activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT parkjaeh activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT peralesmiguelangel activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT poncedorism activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT ramanathanlakshmiv activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT sallesgillesa activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT scordomichael activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT seosusank activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT shahurvia activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT steineytanm activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT strausdavid activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT usmanisaadz activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT youngjamesw activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT zelenetzandrewd activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT noyariela activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies AT vardhanasantoshaa activityofazd7442tixagevimabcilgavimabagainstomicronsarscov2inpatientswithhematologicmalignancies |